Home / Health / Cancer Survivor Runs 100th Parkrun Post-Transplant
Cancer Survivor Runs 100th Parkrun Post-Transplant
10 Oct
Summary
- Patient John Osborn completed his 100th parkrun exactly one year after a stem cell transplant.
- He was diagnosed with myeloma, a blood and bone marrow cancer, after experiencing back and pelvis pain.
- Osborn participated in the Myeloma XV RADAR clinical trial for personalized treatment.
A blood cancer patient has reached a significant personal milestone, completing his 100th parkrun exactly one year after receiving a stem cell transplant. John Osborn, from Paignton, was supported by staff from Torbay Hospital, where he is participating in a clinical trial.
Osborn's diagnosis of myeloma, a cancer affecting the blood and bone marrow, followed the onset of back and pelvis pain. He underwent chemotherapy and, while recovering from his transplant, set his sights on the 100 parkrun goal.
Myeloma cancer involves cancerous blood cells accumulating in the bone marrow, impairing its function. This condition can impact bones, kidneys, and the immune system, and while incurable, it is manageable with available treatments to control the disease and extend life expectancy.
The 65-year-old's participation in the national Myeloma XV RADAR clinical trial involves tailored care based on diagnosis and treatment response. Osborn's achievement demonstrates remarkable determination to regain fitness and accomplish his goal.
